ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Dr Priscilla Caguioa presents her talk at Choosing Wisely Philippines 2023 about choosing wisely in neoadjuvant treatment for different cancers in the Philippines.
She explains the advantages and disadvantages of neoadjuvant treatment and outlines the use of this treatment approach for breast and head and neck cancers with varied examples of recent clinical trials.
Dr Caguioa concludes by highlighting the key takeaway messages for medical professionals on the topic of neoadjuvant treatment for cancer.
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
OncoAlert Round Up for September 15-21, 2023
Targeting BRAF V600E in metastatic colorectal cancer: where are we today?
The advantages of IORT for early breast cancer treatment
Neo-adjuvant therapy for different cancers in the Philippines
Lung cancer screening and treatment in the Philippines
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer
Global adoption of single-shot targeted IORT for breast cancer
IORT at the Asian Hospital and Medical Center